In the last 12 months, insiders at Panbela Therapeutics, Inc. ($PBLA) filed 3 transactions with the SEC: 1 open-market purchases totaling $9,150,000 and 0 sales totaling $0. Net insider sentiment: net buying.
Panbela Therapeutics, Inc. operates in the Pharmaceutical preparations industry (Life sciences sector).
Most Active Insiders
- Nant Capital, LLC (Not found) — 1 transaction totaling $9,150,000
- Horvath Susan (V.P. of Finance & CFO) — 1 transaction totaling $0
- Simpson Jennifer K. (President and CEO) — 1 transaction totaling $0
View all SEC Filings for Panbela Therapeutics, Inc. (PBLA).
Set Up your own filters →Recent Insider Transactions
| Transaction Date | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov. 15, 2024 | Nant Capital, LLC | Not found | P | 8% Senior Convertible Note due 2025 | 9150000 | $9150000.00 | 12,000,000.0000 | 4,854,831 | 321.05% | 100.00% |
| Oct. 1, 2024 | Horvath Susan | V.P. of Finance & CFO | A | Stock Option (right to buy) | 25480 | $0.00 | 25,480.0000 | 4,854,861 | 9999.99% | 0.52% |
| Oct. 1, 2024 | Simpson Jennifer K. | President and CEO | A | Stock Option (right to buy) | 72800 | $0.00 | 72,800.0000 | 4,854,861 | 9999.99% | 1.50% |